US EditionPublished • loading... • Updated
PBM Titans Face Mounting Pressure as Market Set to Near $1 Trillion Amid Regulatory Scrutiny and Drug Pricing Revolution
Summary by NEWS NOW
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PBM Titans Face Mounting Pressure as Market Set to Near $1 Trillion Amid Regulatory Scrutiny and Drug Pricing Revolution
CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx Dominate as Cost and Transparency Concerns Drive Unprecedented Market Growth and Legislative Action. In the high-stakes arena of American healthcare, Pharmacy Benefit Managers (PBMs) the powerful intermediaries between drug manufacturers, insurers, and pharmacies—are simultaneously driving toward staggering market growth and navigating their most significant existential threats in…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
